Skip to content

LENSAR, Inc. LNSR Price / earnings

Price / earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
Staar Surgical logo
Staar SurgicalSTAA
65.5×-34.8×
IAR
Integra LifeSciencesIART
95.8×+70.8×
ITG
Integer HoldingsITGR
21.4×-32.6×
Intuitive Surgical logo
Intuitive SurgicalISRG
55×-16.7×
Medtronic logo
MedtronicMDT
21.7×-1.5×

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-47.4%
Enterprise value$65.21M-49.0%
P/S1.2×-1.1×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on the most recent quarter.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s price / earnings?
LENSAR, Inc. (LNSR) reported price / earnings of 2.4× in Q1 2026.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.